BioPharma, Pharma Akebia Recovers From Rejection to Win FDA Approval for Anemia Drug By Frank Vinluan
BioPharma, Pharma Claiming Akebia agreement breach, Otsuka seeks to end anemia drug pact By Frank Vinluan
BioPharma, Pharma Safety concerns sink Akebia drug for anemia from chronic kidney disease By Frank Vinluan
News Akebia completes Phase I trial of anemia drug, looks toward licensing deal with large pharmaceutical firm By Brandon Glenn
News Cincinnati’s Akebia Therapeutics races (as safely as possible) toward new anemia treatment By Chris Seper
